Dunn Ranch partners with RenoVō Allograft for equestrian programs

Equine Amnio Solutions, LLC, a distributor of next-generation regenerative products, including RenoVō equine allograft, has partnered with Dunn Ranch (Wynnewood and Lexington, Oklahoma).

According to a company statement,1 Dunn Ranch is recognized worldwide in the field of services to stallions and mares, including embryo transfers, foaling, breeding management and sales preparation. Located on 100 acres with innovative amenities, Wynnewood and Lexington sites and facilities ensure animal health and comfort. Dunn Ranch leverages RenoVō in the clinical care of their horses and was the primary owner at the Remington Park Spring Meet which ended on May 28, 2022, marking their second consecutive owner’s title as premier riders .1

Intended for equine use, RenoVō is a cryopreserved acellular liquid allograft derived from equine amniotic tissue. Birth amniotic tissues are key sources of bioactive factors involved in tissue regeneration with reported anti-inflammatory, antibacterial and antifibrotic properties.1 Research has shown the product to be safe and a highly effective alternative to other current clinical equine wound care modalities. RenoVō is manufactured by Equus Innovations (Phoenix, Arizona) and has been used on over 11,000 horses to date.

“RenoVō has been a game-changer for our establishment and for our clientele. There is simply no substitute,” Bendi Dunn, owner of Dunn Ranch, said in the statement. Ginger Johnson of EAS added, “We are delighted to partner with Dunn to support the health of hundreds of horses under their exceptional care.”1

Reference

Dunn Ranch partners with RenoVō Allograft for equestrian programs. Press release. Equine Amnio Solutions, LLC. August 29, 2022. Accessed August 31, 2022. https://www.prnewswire.com/news-releases/dunn-ranch-partners-with-renov-allograft-for-equestrian-programs-301613365.html